129 related articles for article (PubMed ID: 38460194)
1. The Effect of Pushing Rate on Foam Stability in the Tessari Method.
Azmoun S; Liu Y; Bian K; Chen A; Liu S
Dermatol Surg; 2024 Jun; 50(6):542-545. PubMed ID: 38460194
[TBL] [Abstract][Full Text] [Related]
2. A Novel Compound Sclerosant: Polidocanol-Bleomycin Foam.
Hanshu Z; Shaohua L; Anwei C
Dermatol Surg; 2020 Dec; 46(12):1712-1714. PubMed ID: 32769523
[TBL] [Abstract][Full Text] [Related]
3. A Review of Sclerosing Foam Stability in the Treatment of Varicose Veins.
Bai T; Liu Y; Jiang W; Li Y; Liu J; Yu C; Fan Y
Dermatol Surg; 2020 Feb; 46(2):249-257. PubMed ID: 31569112
[TBL] [Abstract][Full Text] [Related]
4. A Modiied 3-Way Tap to Enhance the Stability and Uniformity of Sclerosant Foam.
Zhang H; Yang A; Xu M; Liu S
Ann Vasc Surg; 2021 Jan; 70():501-505. PubMed ID: 32889163
[TBL] [Abstract][Full Text] [Related]
5. Stability of foam in sclerotherapy: differences between sodium tetradecyl sulfate and polidocanol and the type of connector used in the double-syringe system technique.
Rao J; Goldman MP
Dermatol Surg; 2005 Jan; 31(1):19-22. PubMed ID: 15720090
[TBL] [Abstract][Full Text] [Related]
6. Polidocanol concentration and time affect the properties of foam used for sclerotherapy.
VAN Deurzen B; Ceulen RP; Tellings SS; VAN DER Geld C; Nijsten T
Dermatol Surg; 2011 Oct; 37(10):1448-55. PubMed ID: 21790848
[TBL] [Abstract][Full Text] [Related]
7. Bleomycin Polidocanol Foam (BPF) Stability - In Vitro Evidence for the Effectiveness of a Novel Sclerosant for Venous Malformations.
Sun Y; Gu H; Yang X; Cai R; Shang Y; Hu L; Wang Y; Chen H; Lin X
Eur J Vasc Endovasc Surg; 2020 Jun; 59(6):1011-1018. PubMed ID: 32063463
[TBL] [Abstract][Full Text] [Related]
8. The effects of environmental and compositional manipulations on the longevity of Tessari-made foam for sclerotherapy.
Patel SB; Ostler AE; Dos Santos SJ; Piriea TM; Whiteley MS
J Vasc Surg Venous Lymphat Disord; 2015 Jul; 3(3):312-8. PubMed ID: 26992311
[TBL] [Abstract][Full Text] [Related]
9. Properties of polidocanol foam in view of its use in sclerotherapy.
Nastasa V; Samaras K; Ampatzidis Ch; Karapantsios TD; Trelles MA; Moreno-Moraga J; Smarandache A; Pascu ML
Int J Pharm; 2015 Jan; 478(2):588-96. PubMed ID: 25433198
[TBL] [Abstract][Full Text] [Related]
10. An Investigation on the Influence of Hyaluronic Acid on Polidocanol Foam Stability.
Chen AW; Liu YR; Li K; Liu SH
Dermatol Surg; 2016 Jan; 42(1):56-8. PubMed ID: 26671207
[TBL] [Abstract][Full Text] [Related]
11. A modified Tessari method for producing more foam.
Xu J; Wang YF; Chen AW; Wang T; Liu SH
Springerplus; 2016; 5():129. PubMed ID: 26933628
[TBL] [Abstract][Full Text] [Related]
12. Effect of catheter needle caliber on polidocanol foam stability in foam sclerotherapy.
Azmoun S; Liu Y; Tursun M; Liu S
Front Neurol; 2024; 15():1417788. PubMed ID: 38841699
[TBL] [Abstract][Full Text] [Related]
13. Polidocanol foam stability in terms of its association with glycerin.
Rial R; Hervas LS; Monux G; Galindo A; Martin A; Hernando M; Martinez I; Hernando A; Serrano FJ
Phlebology; 2014 Jun; 29(5):304-9. PubMed ID: 23470491
[TBL] [Abstract][Full Text] [Related]
14. A new method for using radiopaque sclerosing foam to treat venous malformations.
Li K; Liu YR; Chen AW; Liu SH
Dermatol Surg; 2015 Jun; 41(6):726-30. PubMed ID: 25973562
[TBL] [Abstract][Full Text] [Related]
15. Novel developments in foam sclerotherapy: Focus on Varithena® (polidocanol endovenous microfoam) in the management of varicose veins.
Star P; Connor DE; Parsi K
Phlebology; 2018 Apr; 33(3):150-162. PubMed ID: 28166694
[TBL] [Abstract][Full Text] [Related]
16. The Stability of Physician-Compounded Foam is Influenced by the Angle of Connector.
Shi X; Liu Y; Li D; Tursun M; Azmoun S; Liu S
Ann Vasc Surg; 2024 Feb; 99():217-222. PubMed ID: 37852364
[TBL] [Abstract][Full Text] [Related]
17. Identifying the Most Stable State of a Foam Sclerosant for Foam Sclerotherapy.
Zhang HS; Yang AJ; Liu S
Dermatol Surg; 2020 Oct; 46(10):e66-e70. PubMed ID: 31895253
[TBL] [Abstract][Full Text] [Related]
18. Does the relative silicone content of different syringes affect the stability of foam in sclerotherapy?
Lai SW; Goldman MP
J Drugs Dermatol; 2008 Apr; 7(4):399-400. PubMed ID: 18459524
[TBL] [Abstract][Full Text] [Related]
19. Modified Tessari Tourbillon technique for making foam sclerotherapy with silicone-free syringes.
Whiteley MS; Patel SB
Phlebology; 2015 Oct; 30(9):614-7. PubMed ID: 25288590
[TBL] [Abstract][Full Text] [Related]
20. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
Uncu H
Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
